NCT06572449View on ClinicalTrials.gov

Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

March 13, 2025

Study Completion Date

March 13, 2025

Conditions
Schizophrenia
Interventions
DRUG

KarXT

Specified dose on specified days

Trial Locations (6)

30030

Local Institution - 0003, Decatur

30331

Local Institution - 0005, Atlanta

33024

Local Institution - 0006, Hollywood

90720-3118

Local Institution - 0002, Los Alamitos

92506-3257

Local Institution - 0004, Riverside

08053-3449

Local Institution - 0001, Marlton

Sponsors
All Listed Sponsors
lead

Karuna Therapeutics

INDUSTRY

NCT06572449 - Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia | Biotech Hunter | Biotech Hunter